4-Phenyl-1-piperidin-4-yl-1,3-dihydro-2H-imidazol-2-one
95%
science Other reagents with same CAS 205058-28-2
blur_circular Chemical Specifications
description Product Description
Used in pharmaceutical research as a key intermediate in the synthesis of centrally acting agents, particularly those targeting neurological pathways. Shows potential in the development of dopamine and sigma receptor modulators, which are relevant for treating psychiatric and neurodegenerative disorders. Also explored for its role in enhancing cognitive function and managing pain due to its affinity for specific neural receptors. Its structure supports blood-brain barrier penetration, making it valuable in CNS drug design. This compound is primarily for laboratory research and not approved for clinical use.